Prioritizing Maternal and Child Health

At a glance

CDC, as a key implementer of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), is a leader in the prevention, care, and treatment of maternal and pediatric HIV and TB disease.

Overview

Mother holding child in waiting room
CDC is a key contributor to PEPFAR's efforts in identifying pregnant and breastfeeding women who are living with HIV.

Globally, in 2023, an estimated 120,000 new HIV infections occurred in children aged 0-14 years. Mother-to-child transmission, also known as vertical transmission, of HIV occurs when the virus passes to the baby during pregnancy, delivery, or through breastfeeding. For a woman living with HIV, there is little risk of transmission when antiretroviral treatment (ART) is taken and effective.

Preventing HIV in infants

Through PEPFAR, CDC supports a comprehensive package of prevention services during pregnancy, labor, and delivery. Since the program began, more than 5.5 million babies have been born HIV-free to mothers living with HIV. Services continue for the mother and infant until the infant's HIV status is known.

CDC supports treatment for pregnant women living with HIV.‎

In 2023, CDC supported treatment for more than 445,000 pregnant women living with HIV – over 60 percent of all pregnant women who received HIV treatment through PEPFAR.

Advancing testing, care, and treatment

Early infant diagnosis

Early infant diagnosis programs test infants exposed to HIV before two months of age to identify and link infants living with HIV to lifesaving ART. At the same time, infants who test HIV-negative are provided preventive care and retested at nine and 18 months.

CDC helped protect 346,000 infants.‎

CDC supported early infant diagnosis for 346,000 infants in 2023.

Pediatric testing and treatment

Globally, 1.37 million children are living with HIV. Without testing and treatment, half of these children will die by the age of two, and 80 percent will not live to their fifth birthday.

The number of children receiving ART also lags behind adults. In 2023, only 57 percent of children living with HIV received treatment, compared to 77 percent of adults.

CDC tests over 3.5 million children for HIV. ‎

In 2023, CDC tested over 3.5 million children and supported treatment for over 300,000 children less than 15 years old living with HIV.

While progress has been made, efforts must continue to find undiagnosed children and connect them to the best treatment options available.

Orphans and vulnerable children

CDC, through PEPFAR, supports orphans and vulnerable children (OVC) programs for those impacted by HIV. Children and adolescents living with HIV, who have lost one or both parents to AIDS, and those at high risk of HIV infection are program priorities. Program goals include:

  • Providing access to HIV testing, care, and treatment for children and adolescents.
  • Preventing HIV and sexual violence through evidence-based interventions.
  • Supporting educational access and completion.
  • Building resilience for HIV-impacted children, adolescents, and their families.

CDC supports OVC programs in six countries. ‎

As of March 2024, CDC has 754,513 beneficiaries enrolled in the family-centered case management OVC programs in Nigeria, Kenya, Zambia, Cote d'Ivoire, the Democratic Republic of Congo, and Haiti.

Improving women's health

Women living with HIV are six times more likely to develop cervical cancer. CDC and PEPFAR support cervical cancer screening and prevention for women living with HIV through the Go Further Initiative.

CDC supported 1.3 million cervical cancer screenings.‎

In 2023, CDC supported 1.3 million cervical cancer screenings among women living with HIV in 12 countries. Of these, nearly 76,000 women screened positive for pre-cancerous lesions, and almost 68,000 received treatment to prevent the further development of cervical cancer

Additionally, some types of cervical cancer can be prevented with the highly effective vaccine for human papillomavirus (HPV) - an infection that causes cervical cancer. CDC collaborates with in-country immunization programs and other partners to support HPV vaccination efforts.

CDC in action